Kinetics of Different Blood Biomarkers during Polymyxin-B Extracorporeal Hemoperfusion in Abdominal Sepsis
Blood Purification · 2024
DOI: 10.1159/000538870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2024. Verfasst von Antonella Cotoia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, University Hospital of Foggia, Foggia, Italy. Hauptthemen laut MEDLINE: Hemoperfusion, Polymyxin B, Biomarkers, Procalcitonin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
Introduction
Comparison of the marker kinetics procalcitonin, presepsin, and endotoxin during extracorporeal hemoperfusion with polymyxin-B adsorbing cartridge (PMX-HA) has never been described in abdominal sepsis. We aimed to compare the trend of three biomarkers in septic post-surgical abdominal patients in intensive care unit (ICU) treated with PMX-HA and their prognostic value.
Methods
Ninety abdominal post-surgical patients were enrolled into different groups according to the evidence of postoperative sepsis or not. Non-septic patients admitted in the surgical ward were included in C group (control group). ICU septic shock patients with endotoxin levels <0.6 EAA receiving conventional therapy were addressed in S group and those with endotoxin levels ≥0.6 EAA receiving treatment with PMX-HA, besides conventional therapy, were included in SPB group. Presepsin, procalcitonin, endotoxin and other clinical data were recorded at 24 h (T0), 72 h (T1) and 7 days (T2) after surgery. Clinical follow-up was performed on day 30.
Results
SPB group showed reduced levels of the three biomarkers on T2 versus T0 (p < 0.001); presepsin, procalcitonin and endotoxin levels decreased, respectively, by 25%, 11%, and 2% on T1 versus T0, and 40%, 41%, and 26% on T2 versus T0. All patients in C group, 73% of patients in SPB group versus 37% of patients in S group survived at follow-up. Moreover, procalcitonin had the highest predictive value for mortality at 30 days, followed by presepsin.
Conclusion
The present study showed the reliability of presepsin in monitoring PMX-HA treatment in septic shock patients. Procalcitonin showed better predicting power for the mortality riSsk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care, University Hospital of Foggia, Foggia, Italy.
- General Surgery Unit, Department of Medical and Surgical Sciences, University Hospital of Foggia, Foggia, Italy.
- Clinical Pathology Unit and Center for Molecular Medicine, Department of Medical and Surgical Sciences, University Hospital of Foggia, Foggia, Italy.
- Department of Surgery, Medical, Molecular, and Critical Area Pathology, University of Pisa, Pisa, Italy.
Zitieren
APA
Cotoia, A., Parisano, V., Mariotti, P. S., Lizzi, V., Netti, G. S., Ranieri, E., Forfori, F., & Cinnella, G. (2024). Kinetics of Different Blood Biomarkers during Polymyxin-B Extracorporeal Hemoperfusion in Abdominal Sepsis. Blood Purification. https://doi.org/10.1159/000538870
Vancouver
Cotoia A, Parisano V, Mariotti PS, Lizzi V, Netti GS, Ranieri E, et al. Kinetics of Different Blood Biomarkers during Polymyxin-B Extracorporeal Hemoperfusion in Abdominal Sepsis. Blood Purification. 2024. doi:10.1159/000538870
BibTeX
@article{Cotoia2024,
author = {Cotoia, Antonella and Parisano, Valeria and Mariotti, Paola Sara and Lizzi, Vincenzo and Netti, Giuseppe Stefano and Ranieri, Elena and Forfori, Francesco and Cinnella, Gilda},
title = {Kinetics of Different Blood Biomarkers during Polymyxin-B Extracorporeal Hemoperfusion in Abdominal Sepsis},
journal = {Blood Purification},
year = {2024},
doi = {10.1159/000538870}
}
EUVIMED